Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL
The HemOnc Pulse
Introduction
Dr. Krish Patel shares insights on lymphoid malignancies, emphasizing the evolving frontline treatment approaches for DLBCL with a focus on the influence of Polaris data and the adoption of polatuzumab-based therapy for non-germinal center B cell DLBCL.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
